Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-24 Tax Withholding | 2024-05-29 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | BLANK BURKHARD EVP Chief Medical Officer | 16,151 | $4.78 | 351,754 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | BLANK BURKHARD EVP Chief Medical Officer | 287,000 | $0 | 654,905 (Direct) | View |
| 2023-12-31 Option Award | 2024-02-05 06:00 am | N/A N/A | MANNKIND CORP | MNKD | BLANK BURKHARD EVP Chief Medical Officer | 5,000 | $3.09 | 367,905 (Direct) | View |
| 2024-02-04 Option Award | 2024-02-05 06:00 am | N/A N/A | MANNKIND CORP | MNKD | BLANK BURKHARD EVP Chief Medical Officer | 152,905 | $3.27 | 367,905 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-26 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | BLANK BURKHARD EVP Chief Medical Officer | 210,000 | $0 | 210,000 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 6:33 pm | N/A N/A | ACORDA THERAPEUTICS INC | ACOR | BLANK BURKHARD CMO and Head of R&D | 11,125 | $0 | 18,527 (Direct) | View |
| 2020-09-17 Option Award | 2020-09-21 08:26 am | N/A N/A | ACORDA THERAPEUTICS INC | ACOR | BLANK BURKHARD CMO and Head of R&D | 3,015 | $0 | 44,410 (Direct) | View |
| 2019-11-07 Option Award | 2019-11-12 07:58 am | N/A 2029-11-07 | ACORDA THERAPEUTICS INC | ACOR | BLANK BURKHARD CMO and Head of R&D | 80,000 | $0 | 80,000 (Direct) | View |